DK2969098T3 - Fremgangsmåder til oprensning af antistoffer - Google Patents

Fremgangsmåder til oprensning af antistoffer Download PDF

Info

Publication number: DK2969098T3
Authority: DK; Denmark
Prior art keywords: procedures; antibodies; cleaning; cleaning antibodies
Prior art date: 2013-03-15

Application number

DK14713926.5T

Other languages

English (en)

Inventor

Kent E Goklen

Eric J Suda

Antonio Raul Ubiera

Original Assignee

Glaxosmithkline Ip No 2 Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2013-03-15

Filing date

2014-03-13

Publication date

2020-01-27

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50391244&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2969098(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2014-03-13 Application filed by Glaxosmithkline Ip No 2 Ltd filed Critical Glaxosmithkline Ip No 2 Ltd

2020-01-27 Application granted granted Critical

2020-01-27 Publication of DK2969098T3 publication Critical patent/DK2969098T3/da

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
- B01D15/3804—Affinity chromatography
- B01D15/3809—Affinity chromatography of the antigen-antibody type, e.g. protein A, G or L chromatography
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/569—Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody®

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Analytical Chemistry (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Chemical Kinetics & Catalysis (AREA)
Peptides Or Proteins (AREA)
Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Treatment Of Liquids With Adsorbents In General (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

DK14713926.5T 2013-03-15 2014-03-13 Fremgangsmåder til oprensning af antistoffer DK2969098T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US201361787309P	2013-03-15	2013-03-15
PCT/IB2014/059755 WO2014141150A1 (en)	2013-03-15	2014-03-13	Methods for purifying antibodies

Publications (1)

Publication Number	Publication Date
DK2969098T3 true DK2969098T3 (da)	2020-01-27

Family

ID=50391244

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK19198005.1T DK3680000T3 (da)	2013-03-15	2014-03-13	Fremgangsmåder til oprensning af antistoffer
DK14713926.5T DK2969098T3 (da)	2013-03-15	2014-03-13	Fremgangsmåder til oprensning af antistoffer

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
DK19198005.1T DK3680000T3 (da)	2013-03-15	2014-03-13	Fremgangsmåder til oprensning af antistoffer

Country Status (15)

Country	Link
US (3)	US10676503B2 (da)
EP (3)	EP2969098B1 (da)
JP (2)	JP6599773B2 (da)
KR (1)	KR102114021B1 (da)
CN (1)	CN105188872B (da)
AU (1)	AU2014229280B2 (da)
BR (1)	BR112015022321A2 (da)
CA (1)	CA2902287A1 (da)
DK (2)	DK3680000T3 (da)
ES (2)	ES2765206T3 (da)
IL (1)	IL240753B (da)
RU (1)	RU2651483C2 (da)
SG (1)	SG11201506494XA (da)
TW (1)	TWI625335B (da)
WO (1)	WO2014141150A1 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2969098B1 (en)	2013-03-15	2019-10-30	Glaxosmithkline Intellectual Property (No. 2) Limited	Methods for purifying antibodies
EP2997036B1 (en)	2013-05-15	2021-03-03	Medimmune Limited	Purification of recombinantly produced polypeptides
US20170044210A1 (en)	2014-04-30	2017-02-16	Novo Nordisk A/S	Methods for the purification of proteins using caprylic acid
CN108064286A (zh)	2015-01-26	2018-05-22	株式会社钟化	突变型免疫球蛋白κ链可变区结合性肽
WO2016121701A1 (ja)	2015-01-26	2016-08-04	株式会社カネカ	免疫グロブリンκ鎖可変領域含有タンパク質精製用アフィニティー分離マトリックス
WO2017195638A1 (ja) *	2016-05-09	2017-11-16	株式会社カネカ	抗体またはκ鎖可変領域含有抗体断片の精製方法
RU2759909C2 (ru) *	2016-09-07	2021-11-18	Глэксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед	Способы очистки антител
CN106939045B (zh) *	2017-05-01	2020-03-31	深圳市国创纳米抗体技术有限公司	一种单克隆抗体细胞培养液澄清的方法
CN108085358A (zh) *	2018-02-08	2018-05-29	保定冀中药业有限公司	一种犬细小病毒单克隆抗体IgG2b-Fab片段的制备方法
TW202003555A (zh) *	2018-03-07	2020-01-16	英商葛蘭素史克智慧財產發展有限公司	用於純化重組多肽之方法
TW202000891A (zh)	2018-03-07	2020-01-01	英商葛蘭素史克智慧財產發展有限公司	純化抗體之方法
US20230302381A1 (en) *	2020-08-18	2023-09-28	Sartorius Bia Separations D.O.O.	Metal-affinity extraction of host cell dna
CN114133446A (zh) *	2021-12-31	2022-03-04	方坦思(上海)生物医药有限公司	单克隆抗体的纯化方法
CN116179582A (zh) *	2022-09-27	2023-05-30	南京医事达生物科技有限公司	一种通用型基因重组蛋白质a亲和纯化填料制备方法和应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS57106673A (en)	1980-12-24	1982-07-02	Chugai Pharmaceut Co Ltd	Dibenzo(b,f)(1,4)oxazepin derivative
GB8607679D0 (en)	1986-03-27	1986-04-30	Winter G P	Recombinant dna product
US5429746A (en) *	1994-02-22	1995-07-04	Smith Kline Beecham Corporation	Antibody purification
US6955917B2 (en)	1997-06-20	2005-10-18	Bayer Healthcare Llc	Chromatographic method for high yield purification and viral inactivation of antibodies
IL127127A0 (en)	1998-11-18	1999-09-22	Peptor Ltd	Small functional units of antibody heavy chain variable regions
DE60203176T2 (de) *	2001-06-01	2006-04-27	Upfront Chromatography A/S, Kopenhagen	Fraktionierung von proteinhaltigen mischungen
PT1419179E (pt)	2001-08-10	2010-03-16	Univ Aberdeen	Domínios de ligação de antigenes
MXPA04011769A (es)	2002-05-31	2005-07-26	Indian Agricultural Council	Deteccion rapida de toxinas cry de bacillus thuringiensis.
CA2557229C (en)	2004-02-27	2012-07-10	Octapharma Ag	A method of providing a purified, virus safe antibody preparation
WO2005113604A2 (en) *	2004-05-14	2005-12-01	Hematech, Llc	Methods for immunoglobulin purification
WO2007109163A2 (en) *	2006-03-16	2007-09-27	Amgen Inc	Wash buffer and method of using
CN101511387A (zh)	2006-09-08	2009-08-19	惠氏公司	使用亲和色谱法纯化蛋白质的精氨酸洗涤液
WO2008085988A1 (en) *	2007-01-05	2008-07-17	Amgen Inc.	Methods of purifying proteins
CN107915769A (zh) *	2011-03-29	2018-04-17	葛兰素史密斯克莱有限责任公司	用于蛋白纯化的缓冲液体系
EP2969098B1 (en) *	2013-03-15	2019-10-30	Glaxosmithkline Intellectual Property (No. 2) Limited	Methods for purifying antibodies
EP2997036B1 (en) *	2013-05-15	2021-03-03	Medimmune Limited	Purification of recombinantly produced polypeptides
CN120904322A (zh)	2013-09-13	2025-11-07	豪夫迈·罗氏有限公司	包含纯化的重组多肽的方法和组合物

2014
- 2014-03-13 EP EP14713926.5A patent/EP2969098B1/en active Active
- 2014-03-13 BR BR112015022321A patent/BR112015022321A2/pt not_active Application Discontinuation
- 2014-03-13 EP EP24155364.3A patent/EP4371996A3/en active Pending
- 2014-03-13 AU AU2014229280A patent/AU2014229280B2/en not_active Ceased
- 2014-03-13 CN CN201480016016.XA patent/CN105188872B/zh active Active
- 2014-03-13 DK DK19198005.1T patent/DK3680000T3/da active
- 2014-03-13 KR KR1020157029042A patent/KR102114021B1/ko active Active
- 2014-03-13 RU RU2015136860A patent/RU2651483C2/ru active
- 2014-03-13 TW TW103108898A patent/TWI625335B/zh active
- 2014-03-13 WO PCT/IB2014/059755 patent/WO2014141150A1/en not_active Ceased
- 2014-03-13 ES ES14713926T patent/ES2765206T3/es active Active
- 2014-03-13 DK DK14713926.5T patent/DK2969098T3/da active
- 2014-03-13 US US14/775,868 patent/US10676503B2/en active Active
- 2014-03-13 EP EP19198005.1A patent/EP3680000B1/en active Active
- 2014-03-13 CA CA2902287A patent/CA2902287A1/en not_active Abandoned
- 2014-03-13 JP JP2015562513A patent/JP6599773B2/ja active Active
- 2014-03-13 ES ES19198005T patent/ES2978309T3/es active Active
- 2014-03-13 SG SG11201506494XA patent/SG11201506494XA/en unknown
2015
- 2015-08-23 IL IL240753A patent/IL240753B/en active IP Right Grant
2019
- 2019-10-03 JP JP2019182562A patent/JP7002511B2/ja active Active
2020
- 2020-05-13 US US15/931,062 patent/US12358945B2/en active Active
2025
- 2025-06-12 US US19/235,815 patent/US20250353878A1/en active Pending

Also Published As

Publication number	Publication date
JP2016519052A (ja)	2016-06-30
KR102114021B1 (ko)	2020-05-22
US10676503B2 (en)	2020-06-09
CN105188872B (zh)	2019-01-15
EP2969098B1 (en)	2019-10-30
JP6599773B2 (ja)	2019-10-30
WO2014141150A1 (en)	2014-09-18
BR112015022321A2 (pt)	2017-07-18
CN105188872A (zh)	2015-12-23
EP4371996A2 (en)	2024-05-22
EP4371996A3 (en)	2024-08-14
US20200277330A1 (en)	2020-09-03
IL240753B (en)	2021-01-31
US12358945B2 (en)	2025-07-15
US20250353878A1 (en)	2025-11-20
CA2902287A1 (en)	2014-09-18
US20160024146A1 (en)	2016-01-28
IL240753A0 (en)	2015-10-29
DK3680000T3 (da)	2024-04-02
EP3680000A1 (en)	2020-07-15
RU2651483C2 (ru)	2018-04-19
RU2015136860A (ru)	2017-04-28
EP3680000B1 (en)	2024-03-13
TW201522365A (zh)	2015-06-16
JP2020019795A (ja)	2020-02-06
AU2014229280A1 (en)	2015-10-01
KR20150131235A (ko)	2015-11-24
AU2014229280B2 (en)	2017-01-05
TWI625335B (zh)	2018-06-01
ES2978309T3 (es)	2024-09-10
JP7002511B2 (ja)	2022-02-21
EP2969098A1 (en)	2016-01-20
SG11201506494XA (en)	2015-09-29
ES2765206T3 (es)	2020-06-08

Publication	Publication Date	Title
DK3336106T3 (da)	2020-07-13	Anti-fcrh5-antistoffer
EP3083682C0 (en)	2024-04-17	DOUBLE SPECIFICITY ANTIBODIES
DK3708583T3 (da)	2022-05-16	Ikke-fucosylerede anti-fgfr2iiib-antistoffer
IL243311A0 (en)	2016-03-31	Novel antibody frameworks
DK2953972T3 (da)	2020-10-12	Fremgangsmåde til udvælgelse af antistoffer mod bcma
DK3083540T3 (da)	2020-02-24	Fremgangsmåde til fremstilling af substituerede phenoxyphenylketoner
DK2969098T3 (da)	2020-01-27	Fremgangsmåder til oprensning af antistoffer
DK3071595T3 (da)	2019-07-01	Humaniseret anti-kallikrein-2-antistof
DK2768857T3 (da)	2020-02-03	Fremgangsmåder til oprensning af antistoffer
DK3327123T3 (da)	2019-11-25	Fremgangsmåder til sekvensering af immunrepertoiret
BR112015019380A2 (pt)	2017-12-12	aprimoramento de fluxos de processos
ME03675B (me)	2020-10-20	Humanizovana ili himerna anтi-cd3 antiтela
LT3049441T (lt)	2020-02-10	Anti-pdl1 antikūnų kompozicija
DK2766392T3 (da)	2019-10-07	Fremgangsmåde til oprensning af antistoffer
DK3016991T3 (da)	2024-08-26	Sammensætninger til formning af væsker
DK3068800T3 (da)	2019-10-21	FcRn-specifikke antistoffer
PL3971212T3 (pl)	2024-05-27	Białka wiążące antygen receptora onkostatyny m
DK3010895T3 (da)	2017-11-20	Fremgangsmåde til fremstilling af 4-propargyleret aminobenzoxazinoner
DK3065790T3 (da)	2021-02-01	Fremgangsmåder til fjernelse af alpha-galactose
DK3332813T3 (da)	2019-06-24	Metode til opregulering af antigenekspression
DK3369724T3 (da)	2021-03-29	Fremgangsmåde til fremstilling af iopamidol
DK2983680T3 (da)	2020-10-26	Forbedring af organer til transplantation
DK3065774T3 (da)	2021-08-23	Anti-CCL17-antistoffer
HRP20190085T1 (hr)	2019-03-08	Anti-cd52 protutijela
UA27558S (uk)	2014-08-11	Лінза